Diagnosis of osteoporosis in statin-treated patients is dose-dependent.

Michael LeutnerCaspar MatzholdLuise BellachCarola DeischingerJürgen HarreiterStefan ThurnerPeter KlimekAlexandra Kautzky-Willer

Published in: Annals of the rheumatic diseases (2019)

Our results show that the diagnosis of osteoporosis in statin-treated patients is dose-dependent. Thus, osteoporosis is underrepresented in low-dose and overrepresented in high-dose statin treatment, demonstrating the importance of future studies' taking dose-dependency into account when investigating the relationship between statins and osteoporosis.

Keyphrases

low dose
end stage renal disease
high dose
postmenopausal women
newly diagnosed
cardiovascular disease
bone mineral density
ejection fraction
chronic kidney disease
coronary artery disease
peritoneal dialysis
type diabetes
patient reported outcomes
stem cell transplantation
current status